0001179110-19-005301.txt : 20190430
0001179110-19-005301.hdr.sgml : 20190430
20190430170923
ACCESSION NUMBER: 0001179110-19-005301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190426
FILED AS OF DATE: 20190430
DATE AS OF CHANGE: 20190430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOVAKOVIC PHEBE N
CENTRAL INDEX KEY: 0001222195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 19783024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
edgar.xml
FORM 4 -
X0306
4
2019-04-26
0
0000001800
ABBOTT LABORATORIES
ABT
0001222195
NOVAKOVIC PHEBE N
C/O GENERAL DYNAMICS CORPORATION,
2941 FAIRVIEW PARK DRIVE, SUITE 100
FALLS CHURCH
VA
22042
1
0
0
0
Common shares without par value
2019-04-26
4
A
0
2241
0
A
26333
D
Option (right to buy)
78.06
2019-04-26
4
A
0
10837
0
A
2019-04-26
2029-04-25
Common shares
10837
10837
D
These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Jessica H. Paik, by Power of Attorney for Phebe N. Novakovic
2019-04-30
EX-24
2
ex24novakovic.txt
Exhibit 24.1
POWER OF ATTORNEY
The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA
H. PAIK, and AARON N. RICE, and each of them individually, as the
undersigned's true and lawful attorney-in-fact and agent, with
full power of substitution and re-substitution, for the
undersigned and in the undersigned's name, place and stead,
to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144
under the Securities Act of 1933 on Form 144, all SEC statements
on Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic
filings, and any amendments to such forms, and to file the same with
all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full
power and authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned
might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be
done by virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.
Date: December 14, 2018
/s/ Phebe N. Novakovic
Signature of Reporting Person
Phebe N. Novakovic
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064